Cleared Special

K260544 - FMD Peripheral Guide Wire F-14 Flex 6 (FDA 510(k) Clearance)

Also includes:
FMD Peripheral Guide Wire F-14 Tapered 40 FMD Peripheral Guide Wire F-18 Flex SP FMD Peripheral Guide Wire F-18 DP 25 FMD Peripheral Guide Wire F-18 Tapered 40
Mar 2026
Decision
30d
Days
Class 2
Risk

K260544 is an FDA 510(k) clearance for the FMD Peripheral Guide Wire F-14 Flex 6. This device is classified as a Wire, Guide, Catheter (Class II - Special Controls, product code DQX).

Submitted by FMD Co., Ltd. (Shibuya-Ku, JP). The FDA issued a Cleared decision on March 20, 2026, 30 days after receiving the submission on February 18, 2026.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1330.

Submission Details

510(k) Number K260544 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 18, 2026
Decision Date March 20, 2026
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQX — Wire, Guide, Catheter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1330